Form 4: Collegium Pharmaceutical Director Gino Santini Receives Stock Grant

Director Gino Santini received 7,693 restricted stock units (RSUs) from Collegium Pharmaceutical, Inc. on May 16, 2024, vesting on May 16, 2025.

Summary

• Gino Santini, a director of Collegium Pharmaceutical, Inc., received 7,693 restricted stock units (RSUs) on May 16, 2024.
• These RSUs represent a contingent right to receive one share of Collegium Pharmaceutical's common stock per RSU.
• The RSUs vest on May 16, 2025, contingent upon Santini's continued service as a director.
• Settlement of the RSUs will occur on the vesting date or, at Santini's election, upon earlier termination of service, death, disability, or a change in control of the Issuer.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, indicating stability and alignment of interests. It's a neutral event with a slightly positive implication for corporate governance.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

This is a standard practice for compensating and incentivizing board members in publicly traded companies. Stock grants are a common way to align the interests of directors with those of shareholders.

Comparison to Industry Standards

• Stock grants to directors are a common practice across the pharmaceutical industry.
• The size of the grant is likely determined by factors such as company size, director responsibilities, and overall compensation strategy.
• Comparable companies such as Teva Pharmaceutical Industries Ltd. and Mylan N.V. (now Viatris Inc.) also utilize stock grants as part of their director compensation packages.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's long-term success.
• Employees may see this as a sign of stability and commitment from the board.

Key Dates